The role of cystatin C as a proteasome inhibitor in multiple myelomaYijing Jiang, Dan Guo, Jie Zhang et al.|Hematology|2020Cited by 19
The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-AnalysisYuwen Jiang, Dan Guo, Hongming Huang et al.|Technology in Cancer Research & Treatment|2022Cited by 17
<p>Coexistence Of A Huge Venous Thromboembolism And Bleeding Tendency In Cytokine Release Syndrome During CAR-T Therapy</p>Haiyan Liu, Hongming Huang, Ye Yang et al.|OncoTargets and Therapy|2019Cited by 10
Type 2 diabetes mellitus does not increase the risk of multiple myeloma: a systematic review and meta-analysisChenlu Zhang, Hongming Huang, Yuou Sha et al.|Translational Cancer Research|2020Cited by 9
lncRNA transcription factor 7 is related to deteriorating clinical features and poor prognosis in multiple myeloma, and its knockdown suppresses disease progression by regulating the miR‑203‑mediated Jagged1‑Notch1 signaling pathwayHaiyan Liu, Hong Liu, Yaodong Shen et al.|Oncology Letters|2021Cited by 6